| __timestamp | Amneal Pharmaceuticals, Inc. | Biogen Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 2232342000 |
| Thursday, January 1, 2015 | 109679000 | 2113100000 |
| Friday, January 1, 2016 | 118757000 | 1947900000 |
| Sunday, January 1, 2017 | 109046000 | 1935500000 |
| Monday, January 1, 2018 | 230435000 | 2106300000 |
| Tuesday, January 1, 2019 | 289598000 | 2374700000 |
| Wednesday, January 1, 2020 | 326727000 | 2504500000 |
| Friday, January 1, 2021 | 365504000 | 2674300000 |
| Saturday, January 1, 2022 | 399700000 | 2403600000 |
| Sunday, January 1, 2023 | 429675000 | 2549700000 |
| Monday, January 1, 2024 | 2403700000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding spending patterns is crucial for strategic planning. Over the past decade, Biogen Inc. and Amneal Pharmaceuticals, Inc. have demonstrated contrasting approaches to their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Biogen's SG&A expenses have consistently been over 10 times higher than Amneal's, reflecting its expansive market reach and robust operational scale. Notably, Biogen's SG&A expenses peaked in 2021, reaching approximately 2.67 billion dollars, while Amneal's expenses showed a steady increase, culminating in a 408% rise from 2014 to 2023. This divergence highlights Biogen's focus on maintaining its market leadership, whereas Amneal's growth trajectory suggests a strategic expansion phase. These insights provide a window into the financial strategies of two key players in the pharmaceutical sector, offering valuable lessons for investors and industry analysts alike.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Biogen Inc.
SG&A Efficiency Analysis: Comparing Novartis AG and Biogen Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Biogen Inc.
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Biogen Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Biogen Inc. or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.